South Rampart Pharma Strengthens Board with Appointment of Ochsner Health CEO Pete November
April 10, 2025
Ochsner’s follow-on investment underscores commitment to advancing SRP-001 as a leading candidate in the burgeoning non-opioid therapeutic space South Rampart Pharma, Inc. , a clinical-stage